AOP ORPHAN PHARMACEUTICALS SWEDEN AB NUF

SE-164 51 KISTA

Finances

Share Ownership

Return on Equity

31,33 %

Current Ratio

1,08

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	2 232 000	1 685 000	1 798 000	1 392 000
Net Income	52 000	39 000	42 000	32 000
Total Assets	2 232 000	1 685 000	1 798 000	1 401 000
Total Equity	166 000	114 000	74 000	32 000

Income (NOK)	2022	2021	2020	2019
Revenue	2 232 000	1 685 000	1 798 000	1 392 000
Expenditure	2 165 000	1 635 000	1 743 000	1 351 000
Operating Profit	67 000	50 000	54 000	42 000
Financial Income	0	0	0	0
Financial Costs	0	0	0	0
Financial Balance	0	0	0	0
Earnings Before Tax	67 000	50 000	54 000	42 000
Tax	15 000	11 000	12 000	9 000
Net Income	52 000	39 000	42 000	32 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	0	0	0	0
Total Current Assets	2 232 000	1 685 000	1 798 000	1 401 000
Total Assets	2 232 000	1 685 000	1 798 000	1 401 000
Total Retained Equity	166 000	114 000	74 000	32 000
Total Equity	166 000	114 000	74 000	32 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	2 066 000	1 571 000	1 723 000	1 369 000
Total Equity and Debt	2 232 000	1 685 000	1 798 000	1 401 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	2 232 000	1 685 000	1 798 000	1 392 000
Other Income	0	0	0	0
Revenue	2 232 000	1 685 000	1 798 000	1 392 000
Cost of Goods Sold	0	0	0	0
Salary Costs	1 775 000	1 513 000	1 601 000	1 088 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	2 165 000	1 635 000	1 743 000	1 351 000
Operating Profit	67 000	50 000	54 000	42 000
Financial Income	0	0	0	0
Financial Costs	0	0	0	0
Financial Balance	0	0	0	0
Dividends	0	0	0	0
Net Income	52 000	39 000	42 000	32 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	0	0	0	0
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	0	0	0	0
Total Current Assets	2 232 000	1 685 000	1 798 000	1 401 000
Total Assets	2 232 000	1 685 000	1 798 000	1 401 000
Total Equity	166 000	114 000	74 000	32 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	3 000	12 000	0	13 000
Unpaid Taxes	135 000	90 000	−52 000	−42 000
Dividends	0	0	0	0
Other Current Debt	1 914 000	1 458 000	1 763 000	1 388 000
Total Current Debt	2 066 000	1 571 000	1 723 000	1 369 000
Total Equity and Debt	2 232 000	1 685 000	1 798 000	1 401 000

Financial indicators	2022	2021	2020	2019
Return on Equity	31,33 %	34,21 %	56,76 %	100 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	3 %	2,97 %	3 %	3,02 %
Current Ratio	1,08	1,07	1,04	1,02
Quick Ratio	1,08	1,07	1,04	1,02
Equity Ratio	0,07	0,07	0,04	0,02
Gross Profit Margin	100 %	100 %	100 %	100 %

Rotate your device to see the full table